4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0001193125-26-007664
Co-Chief Executive Officer sold 7,715 shares at $11.09 ($85,589)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Klee Justin B. Co-Chief Executive Officer | 2026-01-06 | Sale | −7,715 | $11.09 | $85,589 | 3,317,586 | D |
| Open-market sales · 7,715 sh · avg $11.09 · $85,589 | |||||||
Loading xslF345X05/ownership.xml…